{"id":1877,"date":"2019-10-11T14:51:00","date_gmt":"2019-10-11T13:51:00","guid":{"rendered":"https:\/\/www.corsiaffariregolatori.it\/it\/?p=1877"},"modified":"2022-01-13T14:52:52","modified_gmt":"2022-01-13T13:52:52","slug":"strategies-medical-device-assessment","status":"publish","type":"post","link":"https:\/\/www.direnzo.biz\/it\/strategies-medical-device-assessment\/","title":{"rendered":"New strategies for medical device assessment"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">\u201cNew strategies for medical device assessment\u201d is the title of a workshop presented in Rome on 4 October by&nbsp;<strong>Di Renzo Regulatory Affairs<\/strong>, in cooperation with&nbsp;<strong>Merieux NutriSciences<\/strong>. A day of relevant training in the light of the novelties introduced by the publication, and now imminent application (as of&nbsp;<strong>26 May 2020<\/strong>), of the Medical Device Regulation (MDR) 2017\/745.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Scope of the workshop was to examine in depth, from a regulatory as well as more strictly technical point of view, the main changes introduced. This was achieved thanks to the intervention of expert professionals and through discussion with an experienced and interested audience.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">In the first part of the day, the major differences between the Directive (MDD) and the Regulation (MDR) were outlined, stressing the new reclassification rules, focusing on rule 21, that implies the removal of class I for&nbsp;<strong>MDs containing a substance<\/strong>; rule 14, followed by rules 6, 7, 8, 12 and 20, for combined products (drug-medical device); and rule 19 for MDs containing or constituted by&nbsp;<a href=\"https:\/\/www.direnzo.biz\/it\/pmc-e-biocidi\/cosa-sono-biocidi\/commercio-biocidi\/\">nanomaterials<\/a>.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Then, the introduction of new figures such as the responsible person for the compliance with the regulation, the importer and the distributer was examined, along with the UDI, the new coding system for MDs, and EUDAMED, as depository of the history of the medicinal device.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The second part of the course focused on the new edition of ISO 10993-1 with the examination of the new approach to biocompatibility and of how the&nbsp;<strong>chemical and physical characterisation<\/strong>&nbsp;\u2013 a new regulating requirement \u2013 provides important data. It was also discussed how the biological assessment, in the frame of a risk assessment process in compliance with ISO 14971, is needed to ensure DM safety during its whole lifecycle and the importance of the biological assessment plan, generally drafted by a toxicologist.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Finally, the efficacy and safety assessment for medical devices made of nanoparticles was examined.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">It was a day of discussion and debate on innovative topics, to be soon implemented, but on which, however, there is still doubt and perplexity. The Regulation, in fact, established the new principles to be followed, but guidelines and tools to allow its implementation are still missing.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Written By: Ilaria Perretti<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u201cNew strategies for medical device assessment\u201d is the title of a workshop presented in Rome on 4 October by&nbsp;Di Renzo Regulatory Affairs, in cooperation with&nbsp;Merieux NutriSciences. A day of relevant training in the light of the novelties introduced by the publication, and now imminent application (as of&nbsp;26 May 2020), of the Medical Device Regulation (MDR)<br \/><a class=\"moretag\" href=\"https:\/\/www.direnzo.biz\/it\/strategies-medical-device-assessment\/\">+ Read More<\/a><\/p>\n","protected":false},"author":1,"featured_media":1875,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[10],"tags":[],"class_list":["post-1877","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/www.direnzo.biz\/it\/wp-json\/wp\/v2\/posts\/1877","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.direnzo.biz\/it\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.direnzo.biz\/it\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.direnzo.biz\/it\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.direnzo.biz\/it\/wp-json\/wp\/v2\/comments?post=1877"}],"version-history":[{"count":0,"href":"https:\/\/www.direnzo.biz\/it\/wp-json\/wp\/v2\/posts\/1877\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.direnzo.biz\/it\/wp-json\/wp\/v2\/media\/1875"}],"wp:attachment":[{"href":"https:\/\/www.direnzo.biz\/it\/wp-json\/wp\/v2\/media?parent=1877"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.direnzo.biz\/it\/wp-json\/wp\/v2\/categories?post=1877"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.direnzo.biz\/it\/wp-json\/wp\/v2\/tags?post=1877"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}